|
Signal Transduction
Citations 231-240 of 1930 total displayed.
|
Past content
(since May 2000):
|
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
- Zhihong Zeng, Dos D. Sarbassov, Ismael J. Samudio, Karen W. L. Yee, Mark F. Munsell, C. Ellen Jackson, Francis J. Giles, David M. Sabatini, Michael Andreeff, and Marina Konopleva
Blood 2007; 109: 3509-3512.
[Abstract]
[Full text]
[PDF]
The ß-tail domain (ßTD) regulates physiologic ligand binding to integrin CD11b/CD18
- Vineet Gupta, Annette Gylling, José Luis Alonso, Takashi Sugimori, Petre Ianakiev, Jiang-Ping Xiong, and M. Amin Arnaout
Blood 2007; 109: 3513-3520.
[Abstract]
[Full text]
[PDF]
Natural history and early diagnosis of LAD-1/variant syndrome
- Taco W. Kuijpers, Robin van Bruggen, Nanne Kamerbeek, Anton T. J. Tool, Gonul Hicsonmez, Aytemiz Gurgey, Axel Karow, Arthur J. Verhoeven, Karl Seeger, Özden Sanal, Charlotte Niemeyer, and Dirk Roos
Blood 2007; 109: 3529-3537.
[Abstract]
[Full text]
[PDF]
Molecular basis of glutathione reductase deficiency in human blood cells
- Nanne M. Kamerbeek, Rob van Zwieten, Martin de Boer, Gert Morren, Herma Vuil, Natalja Bannink, Carsten Lincke, Koert M. Dolman, Katja Becker, R. Heiner Schirmer, Stephan Gromer, and Dirk Roos
Blood 2007; 109: 3560-3566.
[Abstract]
[Full text]
[PDF]
Aberrant NF- B signaling in lymphoma: mechanisms, consequences, and therapeutic implications
- Philipp J. Jost and Jürgen Ruland
Blood 2007; 109: 2700-2707.
[Abstract]
[Full text]
[PDF]
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma
- Yazan Alsayed, Hai Ngo, Judith Runnels, Xavier Leleu, Ujjal K. Singha, Costas M. Pitsillides, Joel A. Spencer, Teresa Kimlinger, Joanna M. Ghobrial, Xiaoying Jia, Ganwei Lu, Michael Timm, Ashok Kumar, Daniel Côté, Israel Veilleux, Karen E. Hedin, G. David Roodman, Thomas E. Witzig, Andrew L. Kung, Teru Hideshima, Kenneth C. Anderson, Charles P. Lin, and Irene M. Ghobrial
Blood 2007; 109: 2708-2717.
[Abstract]
[Full text]
[PDF]
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling
- Jonathan A. Deane, Michael G. Kharas, Jean S. Oak, Linda N. Stiles, Ji Luo, Travis I. Moore, Hong Ji, Christian Rommel, Lewis C. Cantley, Thomas E. Lane, and David A. Fruman
Blood 2007; 109: 2894-2902.
[Abstract]
[Full text]
[PDF]
Twisted gastrulation (Tsg) is regulated by Tob and enhances TGF-ß signaling in activated T lymphocytes
- Dimitrios Tzachanis, Lequn Li, Esther M. Lafuente, Alla Berezovskaya, Gordon J. Freeman, and Vassiliki A. Boussiotis
Blood 2007; 109: 2944-2952.
[Abstract]
[Full text]
[PDF]
Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
- Pauline Rimmelé, Olivier Kosmider, Patrick Mayeux, Françoise Moreau-Gachelin, and Christel Guillouf
Blood 2007; 109: 3007-3014.
[Abstract]
[Full text]
[PDF]
Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1
- Stefan Nagel, Christof Burek, Letizia Venturini, Michaela Scherr, Hilmar Quentmeier, Corinna Meyer, Andreas Rosenwald, Hans G. Drexler, and Roderick A. F. MacLeod
Blood 2007; 109: 3015-3023.
[Abstract]
[Full text]
[PDF]
|
|
